← Leaderboards
Mark E. Peeples
Research Inst Nationwide Children'S Hosp
$12,658,136
Attributed
$12,949,445
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,758,584 · 12
By mechanism
P01$9,961,751 · 4
R01$8,834,510 · 5
R21$600,323 · 2
R56$362,000 · 1
Top collaborators
- Octavio Ramilo6 shared
- Jianrong Li1 shared
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Joan E. Durbin$11,877,495
- Lauren O Bakaletz$21,163,452
Others in their field
Top investigators on “Respiratory Syncytial Virus”
- John P Moore · Weill Medical College Of Cornell Univ$32,320,703
- Tina V Hartert · Vanderbilt University$26,560,454
- Lawrence Michael Kauvar · Trellis Bioscience, Inc.$16,848,377
- Natasha Bassam Halasa · Vanderbilt University Medical Center$14,704,905
- Arnold S Monto · University Of Michigan At Ann Arbor$14,469,945
- John V Williams · Vanderbilt University$13,043,731
Research focus
Respiratory Syncytial VirusVaccinesCellsInfectionInfantVirusVirus DiseasesRespiratory Syncytial Virus InfectionsChildSiteVirionAttenuatedProteinsGlycoproteinsRespiratoryCell LinePathogenPreventRespiratory Syncytial Virus VaccinesGtp-Binding ProteinsProductionAntiviral AgentsGenesEpithelial
Grant awards (54)
RNA epigenetic modifications in SARS-CoV-2$582,618
R01 · FY2025 · AI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$369,528
R01 · FY2023 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$369,833
R01 · FY2022 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$370,129
R01 · FY2021 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$370,417
R01 · FY2020 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$28,974
R01 · FY2020 · AI · contact PI
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity$1,557,469
P01 · FY2019 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$370,696
R01 · FY2019 · AI · contact PI
Project 2: Dr. Peeples$189,789
P01 · FY2019 · AI · contact PI
Core A: Administrative$95,424
P01 · FY2019 · AI · contact PI
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity$1,488,538
P01 · FY2018 · AI · contact PI
Project 2: Dr. Peeples$189,292
P01 · FY2018 · AI · contact PI
Core A: Administrative$95,174
P01 · FY2018 · AI · contact PI
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity DIVERSITY SUPPLEMENT$36,334
P01 · FY2018 · AI · contact PI
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity$1,487,635
P01 · FY2017 · AI · contact PI
Project 2: Dr. Peeples$124,620
P01 · FY2017 · AI · contact PI
Core A: Administrative$92,359
P01 · FY2017 · AI · contact PI
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity$1,489,165
P01 · FY2016 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$362,000
R01 · FY2016 · AI · contact PI
Mechanism of Respiratory Syncytial Virus Fusion$362,000
R01 · FY2016 · AI · contact PI
Project 2: Dr. Peeples$127,905
P01 · FY2016 · AI · contact PI
Core A: Administrative$93,852
P01 · FY2016 · AI · contact PI
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity$749,998
P01 · FY2015 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$409,000
R01 · FY2015 · AI · contact PI
Mechanism of Respiratory Syncytial Virus Fusion$362,000
R01 · FY2015 · AI · contact PI
Project 2: Dr. Peeples$64,343
P01 · FY2015 · AI · contact PI
Core A: Administrative$47,529
P01 · FY2015 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$444,040
R01 · FY2014 · AI · contact PI
Mechanism of Respiratory Syncytial Virus Fusion$362,000
R01 · FY2014 · AI · contact PI
Mechanism of Respiratory Syncytial Virus Fusion$340,280
R01 · FY2013 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$340,280
R01 · FY2013 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$37,236
R01 · FY2013 · AI · contact PI
Respiratory Syncytial Virus Targeting of the Human Airway Epithelium$362,000
R01 · FY2012 · AI · contact PI
Mechanism of Respiratory Syncytial Virus Fusion$120,666
R01 · FY2012 · AI · contact PI
Mechanism of Respiratory Syncytial Virus Fusion$362,000
R56 · FY2011 · AI · contact PI
Visualizing Interferon-beta Induction In Vivo$216,000
R21 · FY2009 · AI · contact PI
Respiratory Syncytial Virus Based Vectors for CFTR$508,114
P01 · FY2008 · HL · contact PI
Respiratory Syncytial Virus Based Vectors for CFTR$503,966
P01 · FY2007 · HL · contact PI
Generation of a Single-Cycle Virus to Study the Pathogenesis of Nipah Virus$206,823
R21 · FY2007 · AI · contact PI
Respiratory Syncytial Virus Based Vectors for CFTR$349,947
P01 · FY2006 · HL · contact PI
Translational Regulation in Sendai Virus$278,735
R01 · FY2006 · AI · contact PI
Generation of a Single-Cycle Virus to Study the Pathogenesis of Nipah Virus$177,500
R21 · FY2006 · AI · contact PI
Respiratory Syncytial Virus Based Vectors for CFTR$340,062
P01 · FY2005 · HL
Fusion Protein in Respiratory Syncytial Virus Entry$291,370
R01 · FY2005 · AI
Translational Regulation in Sendai Virus$285,441
R01 · FY2005 · AI
Respiratory Syncytial Virus Based Vectors for CFTR$330,236
P01 · FY2004 · HL
Translational Regulation in Sendai Virus$294,858
R01 · FY2004 · AI
Fusion Protein in Respiratory Syncytial Virus Entry$291,999
R01 · FY2004 · AI
Fusion Protein in Respiratory Syncytial Virus Entry$1
R01 · FY2004 · AI
Fusion Protein in Respiratory Syncytial Virus Entry$290,000
R01 · FY2003 · AI
Translational Regulation in Sendai Virus$285,440
R01 · FY2003 · AI
Fusion Protein in Respiratory Syncytial Virus Entry$290,000
R01 · FY2002 · AI
Translational Regulation in Sendai Virus$264,065
R01 · FY2002 · AI
Fusion Protein in Respiratory Syncytial Virus Entry$298,904
R01 · FY2001 · AI